These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3258529)

  • 1. Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide.
    Nakamura S; Kato A; Sakata Y; Aoki N
    Br J Haematol; 1988 Mar; 68(3):313-9. PubMed ID: 3258529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
    Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
    Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
    Krumdieck R; Shaw DR; Huang ST; Poon MC; Rustagi PK
    Am J Med; 1991 May; 90(5):639-45. PubMed ID: 1903026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide.
    Tosetto A; Rodeghiero F; Gatto E; Manotti C; Poli T
    Am J Hematol; 1995 Jan; 48(1):34-9. PubMed ID: 7832189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.
    Ahmad F; Solymoss S; Poon MC; Berube C; Sullivan AK
    Br J Haematol; 1996 Jun; 93(3):700-3. PubMed ID: 8652397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebral haemorrhage due to acquired factor XIII inhibitor--successful response to factor XIII concentrate.
    Daly HM; Carson PJ; Smith JK
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):507-14. PubMed ID: 1768763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII: inherited and acquired deficiency.
    Board PG; Losowsky MS; Miloszewski KJ
    Blood Rev; 1993 Dec; 7(4):229-42. PubMed ID: 8130686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.
    Lorand L; Velasco PT; Rinne JR; Amare M; Miller LK; Zucker ML
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):232-6. PubMed ID: 3422419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism.
    Ogawa Y; Yanagisawa K; Souri M; Mihara M; Naito C; Takizawa M; Ishizaki T; Mitsui T; Handa H; Osaki T; Nojima Y; Ichinose A
    Acta Haematol; 2017; 137(3):141-147. PubMed ID: 28380473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series.
    Tone KJ; James TE; Fergusson DA; Tinmouth A; Tay J; Avey MT; Kilty S; Lalu MM
    Transfus Med Rev; 2016 Jul; 30(3):123-31. PubMed ID: 27167905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acquired FXIII deficiency with severe bleeding symptoms.
    Hayashi T; Kadohira Y; Morishita E; Asakura H; Souri M; Ichinose A
    Haemophilia; 2012 Jul; 18(4):618-20. PubMed ID: 22356719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative therapeutic plasma exchange in a patient with rare Factor XIII inhibitor.
    Smith J; Bodine JS; Cunningham MT; Gooley K; Plapp FV; Dasgupta A; Ye Z
    Transfus Apher Sci; 2023 Jun; 62(3):103654. PubMed ID: 36775674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An IgG inhibitor against coagulation factor XIII: resolution of bleeding after plasma immunoadsorption with staphylococcal protein A.
    Gailani D
    Am J Med; 1992 Jan; 92(1):110-2. PubMed ID: 1731502
    [No Abstract]   [Full Text] [Related]  

  • 15. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.
    Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inhibitor of activated factor XIII, inhibiting fibrin cross-linking but not incorporation of amine into casein.
    Godal HC; Ly B
    Scand J Haematol; 1977 Nov; 19(5):443-8. PubMed ID: 594661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
    Tahlan A; Ahluwalia J
    Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired factor XIII deficiency: a therapeutic challenge.
    Boehlen F; Casini A; Chizzolini C; Mansouri B; Kohler HP; Schroeder V; Reber G; de Moerloose P
    Thromb Haemost; 2013 Mar; 109(3):479-87. PubMed ID: 23306660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report of an acquired factor XIII inhibitor: diagnosis and management.
    Gregory TF; Cooper B
    Proc (Bayl Univ Med Cent); 2006 Jul; 19(3):221-3. PubMed ID: 17252037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.